Skip to main content

Table 3 Secondary outcome. Death by COVID-19. Hepatitis B with or without cirrhosis. Death by covid vs non-hospitalized/hospitalized/ICU combined

From: Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden

Dependent: Severity Death

 

Non-hosp./Hosp/ICU

Dead

OR (univariable)

OR (multivariable)

Hepatitis B

No hepatitis B

836292 (98.6)

11530 (1.4)

-

-

 

Hepatitis B without cirrhosis

2783 (99.2)

22 (0.8)

0.573 (0.365–0.849, p=0.009)

1.003 (0.616–1.548, p=0.990)

 

Hepatitis B with cirrhosis

90 (92.8)

7 (7.2)

5.641 (2.372–11.310, p<0.001)

2.350 (0.921–5.203, p=0.050)

Age

Mean (SD)

43.8 (16.6)

83.1 (9.9)

1.147 (1.145–1.149, p<0.001)

1.133 (1.131–1.136, p<0.001)

Sex

Women

433583 (98.8)

5266 (1.2)

-

-

 

Men

405582 (98.5)

6293 (1.5)

1.278 (1.231–1.326, p<0.001)

2.353 (2.250–2.461, p<0.001)

Region of birth

Northern Europe

645459 (98.5)

10074 (1.5)

-

-

 

Other Europe

37119 (98.8)

449 (1.2)

0.775 (0.704–0.851, p<0.001)

0.956 (0.856–1.066, p=0.424)

 

Africa

17121 (99.4)

110 (0.6)

0.412 (0.339–0.494, p<0.001)

1.336 (1.075–1.642, p=0.007)

 

Asia

100738 (99.4)

597 (0.6)

0.380 (0.349–0.412, p<0.001)

0.851 (0.768–0.942, p=0.002)

 

America

11154 (99.3)

81 (0.7)

0.465 (0.371–0.575, p<0.001)

0.966 (0.751–1.224, p=0.779)

 

Other/missing

27574 (99.1)

248 (0.9)

0.576 (0.506–0.652, p<0.001)

1.041 (0.901–1.198, p=0.579)

COVID-19 Vaccination

0

830242 (98.7)

11272 (1.3)

-

-

 

1

8923 (96.9)

287 (3.1)

2.369 (2.099–2.663, p<0.001)

0.598 (0.524–0.681, p<0.001)

wCCI group (excl liver disease)

0

789545 (99.2)

6585 (0.8)

-

-

 

1–2

28458 (94.2)

1748 (5.8)

7.365 (6.975–7.772, p<0.001)

2.022 (1.896–2.156, p<0.001)

 

3–4

6462 (80.8)

1540 (19.2)

28.574 (26.886–30.353, p<0.001)

2.784 (2.589–2.992, p<0.001)

 

>=5

14700 (89.7)

1686 (10.3)

13.752 (13.000–14.539, p<0.001)

3.008 (2.809–3.221, p<0.001)

Education

Tertiary

323916 (99.4)

1887 (0.6)

-

-

 

Secondary

366704 (98.9)

4214 (1.1)

1.973 (1.868–2.083, p<0.001)

1.199 (1.128–1.276, p<0.001)

 

Primary

129108 (96.2)

5032 (3.8)

6.690 (6.344–7.058, p<0.001)

1.252 (1.175–1.335, p<0.001)

 

Missing

19437 (97.9)

426 (2.1)

3.762 (3.379–4.179, p<0.001)

1.641 (1.426–1.885, p<0.001)

Income

Highest

174801 (99.5)

892 (0.5)

-

-

 

High

175704 (99.6)

680 (0.4)

0.758 (0.686–0.838, p<0.001)

1.089 (0.979–1.209, p=0.115)

 

Middle

174092 (99.3)

1220 (0.7)

1.373 (1.260–1.498, p<0.001)

1.480 (1.348–1.625, p<0.001)

 

Low

166233 (97.4)

4458 (2.6)

5.255 (4.892–5.652, p<0.001)

2.035 (1.877–2.209, p<0.001)

 

Lowest

137646 (97.0)

4293 (3.0)

6.112 (5.688–6.575, p<0.001)

2.372 (2.178–2.585, p<0.001)

 

Missing

10689 (99.9)

16 (0.1)

0.293 (0.171–0.464, p<0.001)

1.333 (0.757–2.184, p=0.285)

  1. Univariable and multivariable (adjusting for all other factors in the column) logistic regression modelling severe COVID-19 (Death). Exposure (Hepatitis B) in three categories (No hepatitis B, hepatitis B without cirrhosis, and hepatitis B with cirrhosis). Frequency (%), and odds ratios (OR) with 95% confidence intervals. ICU: intensive care unit admission. Non-hosp: Non-hospitalised. Hosp: Hospitalised. wCCI: weighted Charlson Comorbidity index